Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

A clinical case of Wegener granulomatosis with ocular involvement

Poster Details

First Author: R.Anjos PORTUGAL

Co Author(s):    L. Vieira   M. Lisboa   A. Cabugueira   V. Maduro   I. Domingues   P. Ferreira

Abstract Details



Purpose:

To describe a case of Wegener granulomatosis with ocular surface involvement.

Setting:

Centro Hospitalar Lisboa Central

Methods:

The authors present a case of an 82 year-old male with progressive visual loss, anorexia and asthenia. The patient had a history of glaucoma, renal insufficiency, chronic sinusitis and was being investigated for non-specific pulmonary lesions. Best corrected visual acuity was 6/10 at the right eye and 3/10 at the left eye. Biomicroscopy revealed bilateral peripheral ulcerative keratitis and bilateral scleromalacia in the temporal-inferior quadrants.

Results:

A complete blood work-up revealed anemia, elevated C-reactive protein (123,7 mg/L) and rheumatoid factor (138 UI/mL). CT-scans showed pulmonary nodular lesions with associated cavitation. A presumptive diagnosis of Wegener granulomatosis was established and treatment with systemic corticotherapy and cyclophosphamide was initiated with stabilization of the ocular and systemic manifestations.

Conclusions:

Wegener granulomatosis is a rare disease that affects small and medium vessels. Although more frequently associated with pulmonary and renal changes, ocular involvement may occur in up to 50% of cases. The ophthalmologist evaluation may be critical to the diagnosis and monitorization of this disease FINANCIAL INTEREST: NONE

Back to Poster listing